Expression of calbindin-D(28k) in a pancreatic islet beta-cell line protects against cytokine-induced apoptosis and necrosis - PubMed (original) (raw)
Expression of calbindin-D(28k) in a pancreatic islet beta-cell line protects against cytokine-induced apoptosis and necrosis
A Rabinovitch et al. Endocrinology. 2001 Aug.
Abstract
Cytokines produced by immune system cells that infiltrate pancreatic islets are candidate mediators of islet beta-cell destruction in autoimmune (type 1) diabetes mellitus. Because the calcium binding protein, calbindin-D(28k), can prevent apoptotic cell death in different cell types, we investigated the possibility that calbindin-D(28k) may prevent cytokine-mediated islet beta-cell destruction. Using the expression vector BSRalpha, rat calbindin-D(28k) was stably expressed in the pancreatic islet beta-cell line, betaTC-3. Calbindin-D(28k) expression resulted in increased cell survival in the presence of the cytotoxic combination of the cytokines IL-1beta (30 U/ml), TNFalpha (10(3) U/ml), and interferon gamma (10(3) U/ml). The greatest protection was observed in the betaTC-3 cell clone expressing the highest concentration of calbindin-D(28k). Apoptotic cell death was detected by annexin V staining and by the TdT-mediated dUTP-X nick end labeling assay in vector-transfected betaTC-3 cells incubated with cytokines (14-15% apoptotic cells). The number of apoptotic cells was significantly decreased in calbindin-D(28k)-overexpressing betaTC-3 cells incubated with cytokines (5-6% apoptotic cells). To address the mechanism of the antiapoptotic effects of calbindin, studies were done to examine whether calbindin inhibits free radical formation. The stimulatory effects of the cytokines on lipid hydroperoxide, nitric oxide, and peroxynitrite production were significantly decreased in the calbindin-D(28k)-expressing betaTC-3 cells. Our findings indicate that calbindin-D(28k), by inhibiting free radical formation, can protect against cytokine-mediated apoptosis and destruction of beta-cells. These findings suggest that calbindin-D(28k) may be an important regulator of cell death that can protect pancreatic islet beta-cells from autoimmune destruction in type 1 diabetes.
Similar articles
- Biological actions and mechanism of action of calbindin in the process of apoptosis.
Christakos S, Liu Y. Christakos S, et al. J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):401-4. doi: 10.1016/j.jsbmb.2004.03.007. J Steroid Biochem Mol Biol. 2004. PMID: 15225809 - Destruction of rat pancreatic islet beta-cells by cytokines involves the production of cytotoxic aldehydes.
Suarez-Pinzon WL, Strynadka K, Rabinovitch A. Suarez-Pinzon WL, et al. Endocrinology. 1996 Dec;137(12):5290-6. doi: 10.1210/endo.137.12.8940348. Endocrinology. 1996. PMID: 8940348 - Calbindin-D(28k) controls Ca(2+) and insulin release. Evidence obtained from calbindin-d(28k) knockout mice and beta cell lines.
Sooy K, Schermerhorn T, Noda M, Surana M, Rhoten WB, Meyer M, Fleischer N, Sharp GW, Christakos S. Sooy K, et al. J Biol Chem. 1999 Nov 26;274(48):34343-9. doi: 10.1074/jbc.274.48.34343. J Biol Chem. 1999. PMID: 10567411 - Vitamin D target proteins: function and regulation.
Christakos S, Barletta F, Huening M, Dhawan P, Liu Y, Porta A, Peng X. Christakos S, et al. J Cell Biochem. 2003 Feb 1;88(2):238-44. doi: 10.1002/jcb.10349. J Cell Biochem. 2003. PMID: 12520521 Review. - Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus.
Rabinovitch A, Suarez-Pinzon WL. Rabinovitch A, et al. Biochem Pharmacol. 1998 Apr 15;55(8):1139-49. doi: 10.1016/s0006-2952(97)00492-9. Biochem Pharmacol. 1998. PMID: 9719467 Review.
Cited by
- Vitamin D efficacy in type 1 and type 2 diabetes.
Kawahara T, Okada Y, Tanaka Y. Kawahara T, et al. J Bone Miner Metab. 2024 Jul;42(4):438-446. doi: 10.1007/s00774-024-01509-3. Epub 2024 Apr 25. J Bone Miner Metab. 2024. PMID: 38664254 Review. - Brain fatty acid and transcriptome profiles of pig fed diets with different levels of soybean oil.
da Silva BP, Fanalli SL, Gomes JD, de Almeida VV, Fukumasu H, Freitas FAO, Moreira GCM, Silva-Vignato B, Reecy JM, Koltes JE, Koltes D, de Carvalho Balieiro JC, de Alencar SM, da Silva JPM, Coutinho LL, Afonso J, Regitano LCA, Mourão GB, Luchiari Filho A, Cesar ASM. da Silva BP, et al. BMC Genomics. 2023 Feb 28;24(1):91. doi: 10.1186/s12864-023-09188-6. BMC Genomics. 2023. PMID: 36855067 Free PMC article. - Relationship Between Vitamin D Levels and β Cell Function and Insulin Resistance.
Ozcan C, Corapcıoglu D, Cerit ET. Ozcan C, et al. Cureus. 2023 Jan 19;15(1):e33970. doi: 10.7759/cureus.33970. eCollection 2023 Jan. Cureus. 2023. PMID: 36820117 Free PMC article. - Effects of enalapril and paricalcitol treatment on diabetic nephropathy and renal expressions of TNF-α, p53, caspase-3 and Bcl-2 in STZ-induced diabetic rats.
Ahmed OM, Ali TM, Abdel Gaid MA, Elberry AA. Ahmed OM, et al. PLoS One. 2019 Sep 17;14(9):e0214349. doi: 10.1371/journal.pone.0214349. eCollection 2019. PLoS One. 2019. PMID: 31527864 Free PMC article. - Role of Calbindin-D28k in Diabetes-Associated Advanced Glycation End-Products-Induced Renal Proximal Tubule Cell Injury.
Huang KH, Guan SS, Lin WH, Wu CT, Sheu ML, Chiang CK, Liu SH. Huang KH, et al. Cells. 2019 Jun 30;8(7):660. doi: 10.3390/cells8070660. Cells. 2019. PMID: 31262060 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources